APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Breakthrough Therapy Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Breakthrough Therapy Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173972530322 December 2025181 pages

Choose your research edition.

Industry ResearchBreakthrough Therapy Drugs Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Breakthrough Therapy Drugs Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Breakthrough Therapy Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Breakthrough Therapy Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Breakthrough Therapy Drugs Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Breakthrough Therapy Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Breakthrough Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Breakthrough Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Breakthrough Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Breakthrough Therapy Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Breakthrough Therapy Drugs include Novartis, Merck, Pfizer, AbbVie, Vertex Pharmaceuticals Incorporated, Gilead, Genentech and Bristol-Myers Squibb Company, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Breakthrough Therapy Drugs market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Breakthrough Therapy Drugs and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Breakthrough Therapy Drugs revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Breakthrough Therapy Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Breakthrough Therapy Drugs Segment by Company

Novartis

Merck

Pfizer

AbbVie

Vertex Pharmaceuticals Incorporated

Gilead

Genentech

Bristol-Myers Squibb Company

Breakthrough Therapy Drugs Segment by Type

Oncology

Neurology

Anti-Viral

Others

Breakthrough Therapy Drugs Segment by Application

Ambulatory Services

Hospitals

Clinics

Breakthrough Therapy Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breakthrough Therapy Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Breakthrough Therapy Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breakthrough Therapy Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Breakthrough Therapy Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Breakthrough Therapy Drugs industry.

Chapter 3: Detailed analysis of Breakthrough Therapy Drugs companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Breakthrough Therapy Drugsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Breakthrough Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oncology Table 3. Key Players of Neurology Table 4. Key Players of Anti-Viral Table 3. Key Players of Others Table 4. Global Breakthrough Therapy Drugs Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Ambulatory Services Table 6. Key Players of Hospitals Table 7. Key Players of Clinics Table 8. Global Breakthrough Therapy Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Breakthrough Therapy Drugs Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Breakthrough Therapy Drugs Market Share by Region (2021-2026) Table 11. Global Breakthrough Therapy Drugs Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Breakthrough Therapy Drugs Market Share by Region (2027-2032) Table 13. Breakthrough Therapy Drugs Industry Trends Table 14. Breakthrough Therapy Drugs Industry Drivers Table 15. Breakthrough Therapy Drugs Industry Opportunities and Challenges Table 16. Breakthrough Therapy Drugs Industry Restraints Table 17. Global Breakthrough Therapy Drugs Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Breakthrough Therapy Drugs Revenue Market Share by Company (2021-2026) Table 19. Global Breakthrough Therapy Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Breakthrough Therapy Drugs Key Company Head Office and Area Served Table 21. Global Breakthrough Therapy Drugs Company, Product Type & Application Table 22. Global Breakthrough Therapy Drugs Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Breakthrough Therapy Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Breakthrough Therapy Drugs Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Breakthrough Therapy Drugs Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Breakthrough Therapy Drugs Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2021-2026) Table 29. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2027-2032) Table 30. Global Breakthrough Therapy Drugs Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Breakthrough Therapy Drugs Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Breakthrough Therapy Drugs Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2021-2026) Table 34. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2027-2032) Table 35. Novartis Company Information Table 36. Novartis Business Overview Table 37. Novartis Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Novartis Breakthrough Therapy Drugs Product Portfolio Table 39. Novartis Recent Development Table 40. Merck Company Information Table 41. Merck Business Overview Table 42. Merck Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Merck Breakthrough Therapy Drugs Product Portfolio Table 44. Merck Recent Development Table 45. Pfizer Company Information Table 46. Pfizer Business Overview Table 47. Pfizer Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Pfizer Breakthrough Therapy Drugs Product Portfolio Table 49. Pfizer Recent Development Table 50. AbbVie Company Information Table 51. AbbVie Business Overview Table 52. AbbVie Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. AbbVie Breakthrough Therapy Drugs Product Portfolio Table 54. AbbVie Recent Development Table 55. Vertex Pharmaceuticals Incorporated Company Information Table 56. Vertex Pharmaceuticals Incorporated Business Overview Table 57. Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product Portfolio Table 59. Vertex Pharmaceuticals Incorporated Recent Development Table 60. Gilead Company Information Table 61. Gilead Business Overview Table 62. Gilead Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Gilead Breakthrough Therapy Drugs Product Portfolio Table 64. Gilead Recent Development Table 65. Genentech Company Information Table 66. Genentech Business Overview Table 67. Genentech Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Genentech Breakthrough Therapy Drugs Product Portfolio Table 69. Genentech Recent Development Table 70. Bristol-Myers Squibb Company Company Information Table 71. Bristol-Myers Squibb Company Business Overview Table 72. Bristol-Myers Squibb Company Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product Portfolio Table 74. Bristol-Myers Squibb Company Recent Development Table 75. North America Breakthrough Therapy Drugs Market Size by Type (2021-2026) & (US$ Million) Table 76. North America Breakthrough Therapy Drugs Market Size by Type (2027-2032) & (US$ Million) Table 77. North America Breakthrough Therapy Drugs Market Size by Application (2021-2026) & (US$ Million) Table 78. North America Breakthrough Therapy Drugs Market Size by Application (2027-2032) & (US$ Million) Table 79. North America Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Breakthrough Therapy Drugs Market Size by Country (2021-2026) Table 81. North America Breakthrough Therapy Drugs Market Size by Country (2027-2032) Table 82. Europe Breakthrough Therapy Drugs Market Size by Type (2021-2026) & (US$ Million) Table 83. Europe Breakthrough Therapy Drugs Market Size by Type (2027-2032) & (US$ Million) Table 84. Europe Breakthrough Therapy Drugs Market Size by Application (2021-2026) & (US$ Million) Table 85. Europe Breakthrough Therapy Drugs Market Size by Application (2027-2032) & (US$ Million) Table 86. Europe Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Breakthrough Therapy Drugs Market Size by Country (2021-2026) Table 88. Europe Breakthrough Therapy Drugs Market Size by Country (2027-2032) Table 89. China Breakthrough Therapy Drugs Market Size by Type (2021-2026) & (US$ Million) Table 90. China Breakthrough Therapy Drugs Market Size by Type (2027-2032) & (US$ Million) Table 91. China Breakthrough Therapy Drugs Market Size by Application (2021-2026) & (US$ Million) Table 92. China Breakthrough Therapy Drugs Market Size by Application (2027-2032) & (US$ Million) Table 93. Asia Breakthrough Therapy Drugs Market Size by Type (2021-2026) & (US$ Million) Table 94. Asia Breakthrough Therapy Drugs Market Size by Type (2027-2032) & (US$ Million) Table 95. Asia Breakthrough Therapy Drugs Market Size by Application (2021-2026) & (US$ Million) Table 96. Asia Breakthrough Therapy Drugs Market Size by Application (2027-2032) & (US$ Million) Table 97. Asia Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Breakthrough Therapy Drugs Market Size by Country (2021-2026) Table 99. Asia Breakthrough Therapy Drugs Market Size by Country (2027-2032) Table 100. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2021-2026) & (US$ Million) Table 101. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2027-2032) & (US$ Million) Table 102. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2021-2026) Table 106. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Breakthrough Therapy Drugs Product Image Figure 2. Global Breakthrough Therapy Drugs Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Breakthrough Therapy Drugs Market Share by Type: 2025 VS 2032 Figure 4. Oncology Image Figure 5. Neurology Image Figure 6. Anti-Viral Image Figure 7. Others Image Figure 8. Global Breakthrough Therapy Drugs Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Breakthrough Therapy Drugs Market Share by Application: 2025 VS 2032 Figure 10. Ambulatory Services Image Figure 11. Hospitals Image Figure 12. Clinics Image Figure 13. Global Breakthrough Therapy Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 15. Global Breakthrough Therapy Drugs Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Breakthrough Therapy Drugs Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Breakthrough Therapy Drugs Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Breakthrough Therapy Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Breakthrough Therapy Drugs Revenue Market Share by Type (2021-2032) Figure 22. Global Breakthrough Therapy Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Breakthrough Therapy Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 25. North America Breakthrough Therapy Drugs Market Share by Type (2021-2032) Figure 26. North America Breakthrough Therapy Drugs Market Share by Application (2021-2032) Figure 27. North America Breakthrough Therapy Drugs Market Share by Country (2021-2032) Figure 28. United States Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 29. Canada Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 31. Europe Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 32. Europe Breakthrough Therapy Drugs Market Share by Type (2021-2032) Figure 33. Europe Breakthrough Therapy Drugs Market Share by Application (2021-2032) Figure 34. Europe Breakthrough Therapy Drugs Market Share by Country (2021-2032) Figure 35. Germany Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 36. France Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 38. Italy Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 39. Russia Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 41. China Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 42. China Breakthrough Therapy Drugs Market Share by Type (2021-2032) Figure 43. China Breakthrough Therapy Drugs Market Share by Application (2021-2032) Figure 44. Asia Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 45. Asia Breakthrough Therapy Drugs Market Share by Type (2021-2032) Figure 46. Asia Breakthrough Therapy Drugs Market Share by Application (2021-2032) Figure 47. Asia Breakthrough Therapy Drugs Market Share by Country (2021-2032) Figure 48. Japan Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 52. India Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 53. Australia Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Breakthrough Therapy Drugs Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Breakthrough Therapy Drugs Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Breakthrough Therapy Drugs Market Share by Country (2021-2032) Figure 58. Brazil Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 63. UAE Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 65. Chile Breakthrough Therapy Drugs Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oncology
  • Neurology
  • Anti-Viral
  • Others
Applications
  • Ambulatory Services
  • Hospitals
  • Clinics
Companies covered
  • Novartis
  • Merck
  • Pfizer
  • AbbVie
  • Vertex Pharmaceuticals Incorporated
  • Gilead
  • Genentech
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Breakthrough Therapy Drugs Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oncology
  5. 1.2.3 Neurology
  6. 1.2.4 Anti-Viral
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Breakthrough Therapy Drugs Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Ambulatory Services
  11. 1.3.3 Hospitals
  12. 1.3.4 Clinics
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Breakthrough Therapy Drugs Growth Trends by Region
  15. 1.5.1 Global Breakthrough Therapy Drugs Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Breakthrough Therapy Drugs Market Size by Region (2021-2026)
  17. 1.5.3 Breakthrough Therapy Drugs Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Breakthrough Therapy Drugs Market Dynamics
  1. 2.1 Breakthrough Therapy Drugs Industry Trends
  2. 2.2 Breakthrough Therapy Drugs Industry Drivers
  3. 2.3 Breakthrough Therapy Drugs Industry Opportunities and Challenges
  4. 2.4 Breakthrough Therapy Drugs Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Breakthrough Therapy Drugs Revenue by Company (2021-2026)
  2. 3.2 Global Breakthrough Therapy Drugs Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Breakthrough Therapy Drugs Key Company Head office and Area Served
  4. 3.4 Global Breakthrough Therapy Drugs Company, Product Type & Application
  5. 3.5 Global Breakthrough Therapy Drugs Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Breakthrough Therapy Drugs Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Breakthrough Therapy Drugs Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Breakthrough Therapy Drugs Tier 1, Tier 2, and Tier 3
4 Breakthrough Therapy Drugs Market by Type
  1. 4.1 Global Breakthrough Therapy Drugs Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Breakthrough Therapy Drugs Market Size by Type (2021-2032)
  3. 4.3 Global Breakthrough Therapy Drugs Market Size Share by Type (2021-2032)
5 Breakthrough Therapy Drugs Market by Application
  1. 5.1 Global Breakthrough Therapy Drugs Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Breakthrough Therapy Drugs Market Size by Application (2021-2032)
  3. 5.3 Global Breakthrough Therapy Drugs Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Novartis Breakthrough Therapy Drugs Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Merck
  8. 6.2.1 Merck Company Information
  9. 6.2.2 Merck Business Overview
  10. 6.2.3 Merck Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Merck Breakthrough Therapy Drugs Product Portfolio
  12. 6.2.5 Merck Recent Developments
  13. 6.3 Pfizer
  14. 6.3.1 Pfizer Company Information
  15. 6.3.2 Pfizer Business Overview
  16. 6.3.3 Pfizer Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Pfizer Breakthrough Therapy Drugs Product Portfolio
  18. 6.3.5 Pfizer Recent Developments
  19. 6.4 AbbVie
  20. 6.4.1 AbbVie Company Information
  21. 6.4.2 AbbVie Business Overview
  22. 6.4.3 AbbVie Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AbbVie Breakthrough Therapy Drugs Product Portfolio
  24. 6.4.5 AbbVie Recent Developments
  25. 6.5 Vertex Pharmaceuticals Incorporated
  26. 6.5.1 Vertex Pharmaceuticals Incorporated Company Information
  27. 6.5.2 Vertex Pharmaceuticals Incorporated Business Overview
  28. 6.5.3 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Vertex Pharmaceuticals Incorporated Breakthrough Therapy Drugs Product Portfolio
  30. 6.5.5 Vertex Pharmaceuticals Incorporated Recent Developments
  31. 6.6 Gilead
  32. 6.6.1 Gilead Company Information
  33. 6.6.2 Gilead Business Overview
  34. 6.6.3 Gilead Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Gilead Breakthrough Therapy Drugs Product Portfolio
  36. 6.6.5 Gilead Recent Developments
  37. 6.7 Genentech
  38. 6.7.1 Genentech Company Information
  39. 6.7.2 Genentech Business Overview
  40. 6.7.3 Genentech Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Genentech Breakthrough Therapy Drugs Product Portfolio
  42. 6.7.5 Genentech Recent Developments
  43. 6.8 Bristol-Myers Squibb Company
  44. 6.8.1 Bristol-Myers Squibb Company Company Information
  45. 6.8.2 Bristol-Myers Squibb Company Business Overview
  46. 6.8.3 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Bristol-Myers Squibb Company Breakthrough Therapy Drugs Product Portfolio
  48. 6.8.5 Bristol-Myers Squibb Company Recent Developments
7 North America
  1. 7.1 North America Breakthrough Therapy Drugs Market Size (2021-2032)
  2. 7.2 North America Breakthrough Therapy Drugs Market Size by Type
  3. 7.2.1 North America Breakthrough Therapy Drugs Market Size by Type (2021-2026)
  4. 7.2.2 North America Breakthrough Therapy Drugs Market Size by Type (2027-2032)
  5. 7.2.3 North America Breakthrough Therapy Drugs Market Share by Type (2021-2032)
  6. 7.3 North America Breakthrough Therapy Drugs Market Size by Application
  7. 7.3.1 North America Breakthrough Therapy Drugs Market Size by Application (2021-2026)
  8. 7.3.2 North America Breakthrough Therapy Drugs Market Size by Application (2027-2032)
  9. 7.3.3 North America Breakthrough Therapy Drugs Market Share by Application (2021-2032)
  10. 7.4 North America Breakthrough Therapy Drugs Market Size by Country
  11. 7.4.1 North America Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Breakthrough Therapy Drugs Market Size by Country (2021-2026)
  13. 7.4.3 North America Breakthrough Therapy Drugs Market Size by Country (2027-2032)
  14. 7.4.4 North America Breakthrough Therapy Drugs Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Breakthrough Therapy Drugs Market Size (2021-2032)
  2. 8.2 Europe Breakthrough Therapy Drugs Market Size by Type
  3. 8.2.1 Europe Breakthrough Therapy Drugs Market Size by Type (2021-2026)
  4. 8.2.2 Europe Breakthrough Therapy Drugs Market Size by Type (2027-2032)
  5. 8.2.3 Europe Breakthrough Therapy Drugs Market Share by Type (2021-2032)
  6. 8.3 Europe Breakthrough Therapy Drugs Market Size by Application
  7. 8.3.1 Europe Breakthrough Therapy Drugs Market Size by Application (2021-2026)
  8. 8.3.2 Europe Breakthrough Therapy Drugs Market Size by Application (2027-2032)
  9. 8.3.3 Europe Breakthrough Therapy Drugs Market Share by Application (2021-2032)
  10. 8.4 Europe Breakthrough Therapy Drugs Market Size by Country
  11. 8.4.1 Europe Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Breakthrough Therapy Drugs Market Size by Country (2021-2026)
  13. 8.4.3 Europe Breakthrough Therapy Drugs Market Size by Country (2027-2032)
  14. 8.4.4 Europe Breakthrough Therapy Drugs Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Breakthrough Therapy Drugs Market Size (2021-2032)
  2. 9.2 China Breakthrough Therapy Drugs Market Size by Type
  3. 9.2.1 China Breakthrough Therapy Drugs Market Size by Type (2021-2026)
  4. 9.2.2 China Breakthrough Therapy Drugs Market Size by Type (2027-2032)
  5. 9.2.3 China Breakthrough Therapy Drugs Market Share by Type (2021-2032)
  6. 9.3 China Breakthrough Therapy Drugs Market Size by Application
  7. 9.3.1 China Breakthrough Therapy Drugs Market Size by Application (2021-2026)
  8. 9.3.2 China Breakthrough Therapy Drugs Market Size by Application (2027-2032)
  9. 9.3.3 China Breakthrough Therapy Drugs Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Breakthrough Therapy Drugs Market Size (2021-2032)
  2. 10.2 Asia Breakthrough Therapy Drugs Market Size by Type
  3. 10.2.1 Asia Breakthrough Therapy Drugs Market Size by Type (2021-2026)
  4. 10.2.2 Asia Breakthrough Therapy Drugs Market Size by Type (2027-2032)
  5. 10.2.3 Asia Breakthrough Therapy Drugs Market Share by Type (2021-2032)
  6. 10.3 Asia Breakthrough Therapy Drugs Market Size by Application
  7. 10.3.1 Asia Breakthrough Therapy Drugs Market Size by Application (2021-2026)
  8. 10.3.2 Asia Breakthrough Therapy Drugs Market Size by Application (2027-2032)
  9. 10.3.3 Asia Breakthrough Therapy Drugs Market Share by Application (2021-2032)
  10. 10.4 Asia Breakthrough Therapy Drugs Market Size by Country
  11. 10.4.1 Asia Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Breakthrough Therapy Drugs Market Size by Country (2021-2026)
  13. 10.4.3 Asia Breakthrough Therapy Drugs Market Size by Country (2027-2032)
  14. 10.4.4 Asia Breakthrough Therapy Drugs Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Breakthrough Therapy Drugs Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Breakthrough Therapy Drugs Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Breakthrough Therapy Drugs Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Breakthrough Therapy Drugs Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst